Skip to content
Screener

Apogee Therapeutics, Inc. APGE Prepaid & Other Current

Prepaid & Other Current at other companies

Eli Lilly logo
Eli LillyLLY
$15.37B-14.7%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$801.7M+39.6%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$20.44M+81.2%
AbbVie logo
AbbVieABBV
$150M-97.3%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$3.91M-26.2%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$7.61M+300%

Other financials

Income statement

See full
Operating income-$82.8M-31.2%
Net income-$74.1M-33.9%
EPS (diluted)-$1.06-11.6%

Balance sheet

See full
Cash & equivalents$451.8M+323%
Total debt$8.0M-31.9%
Total assets$1.3B+81.1%

Cash flow

See full
Operating cash flow-$55.6M-14.6%
CapEx$62.0K
Free cash flow-$62.8M+7.3%

Valuation

See full
Market cap$10.2B+394%
Enterprise value$9.75B+400%

Returns & leverage

See full
Current ratio32.6×+16.8×

Where this comes from

Reported directly by Apogee Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The source filing: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 7:20 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-215698
Line itemMARCH 31,2026DECEMBER 31,2025
Current assets:
Cash and cash equivalents$451,797$131,549
Marketable securities608,088598,643
Prepaid expenses and other current assets13,91211,166
Total current assets1,073,797741,358
Long-term marketable securities198,354172,730
Property and equipment, net5,2805,688
Right-of-use asset, net7,7078,687

Item 6. [Exhibits](#item_6_exhibits) [71](#item_6_exhibits)

FAQ

What is Apogee Therapeutics, Inc.'s prepaid & other current?
Apogee Therapeutics, Inc. (APGE) reported prepaid & other current of $13.91M in Q1 2026.
How has Apogee Therapeutics, Inc.'s prepaid & other current changed year-over-year?
Apogee Therapeutics, Inc.'s prepaid & other current increased by 69.6% year-over-year, from $8.2M to $13.91M.
What is the long-term trend for Apogee Therapeutics, Inc.'s prepaid & other current?
Over 3 years (2022 to 2025), Apogee Therapeutics, Inc.'s prepaid & other current has grown at a 307.5% compound annual growth rate (CAGR), from $165K to $11.17M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.

Ask your AI about Apogee Therapeutics, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude